Task: Answer the multiple choice question.
Question: Which drug exhibits a -12.269% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) COc1ccc(CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
(b) CC(C)=CCCC(C)CN1CCC(n2nccc2NC(=O)C2CCCC2)CC1
(c) CCCCN(C)CCCNC(=O)c1cc(-c2cccnc2)nc2ccccc12
(d) CC1(C)CC(CC(=O)O)(c2ccc(Cl)cc2)CCO1
Answer: a. COc1ccc(CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
COc1ccc(CCNS(=O)(=O)c2cccc3nsnc23)cc1OC
N-[2-(4,5-dimethoxyphenyl)ethyl]-2,1,3-benzothiadiazole-4-sulfonamide